Tech Company Financing Transactions

Wheeler Bio Funding Round

Wheeler Bio, operating out of Oklahoma City, , received $31 million from Charles River Laboratories, Echo and Alloy Therapeutics.

Transaction Overview

Company Name
Announced On
4/13/2023
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to complete its CGMP cell banking and drug substance manufacturing facility (500 L scale) in The Ziggurat, a downtown Oklahoma City office tower.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
The Ziggurat 120 Robert South Kerr Avenue
Oklahoma City, , OK 73102
USA
Phone
Undisclosed
Email Address
Overview
Wheeler Bio brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck with a unique partnering model, built on shared success and lasting collaborations. The typical momentum drop between discovery and development poses significant challenges for emerging biopharma companies adding technical, financial, and regulatory risks. We believe these lifecycle challenges can be reduced with more democratization of manufacturing platforms.
Profile
Wheeler Bio LinkedIn Company Profile
Social Media
Wheeler Bio Company Twitter Account
Company News
Wheeler Bio News
Facebook
Wheeler Bio on Facebook
YouTube
Wheeler Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jesse McCool
  Jesse McCool LinkedIn Profile  Jesse McCool Twitter Account  Jesse McCool News  Jesse McCool on Facebook
Chief Financial Officer
Matt Hamilton
  Matt Hamilton LinkedIn Profile  Matt Hamilton Twitter Account  Matt Hamilton News  Matt Hamilton on Facebook
Chief Operating Officer
Roger Lias
  Roger Lias LinkedIn Profile  Roger Lias Twitter Account  Roger Lias News  Roger Lias on Facebook
Chief Technical Officer
Stephen Hamilton
  Stephen Hamilton LinkedIn Profile  Stephen Hamilton Twitter Account  Stephen Hamilton News  Stephen Hamilton on Facebook
Co-Founder
Yuk Chun
  Yuk Chun  LinkedIn Profile  Yuk Chun  Twitter Account  Yuk Chun  News  Yuk Chun  on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/13/2023: Ampersand venture capital transaction
Next: 4/13/2023: Omy Laboratoires venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary